Alzheimer'S Disease Clinical Trials in Las Vegas, NV

View the best 10 alzheimer's disease medical studies in Las Vegas, Nevada. Access promising new therapies by applying to a Las Vegas-based Alzheimer'S Disease clinical trial.

Trials in Las Vegas, Nevada

Here are the top 6 medical studies for alzheimer's disease in Las Vegas, Nevada

Polypill

Fixed Dose Combination

Recruiting0 awardsPhase 2

This trial aims to see how well a combination drug called a polypill works for patients with Alzheimer's Disease over 180 days. They will include male and female patients aged 50-85 with

AR1001

Recruiting1 awardPhase 3

This trial tests AR1001, a medicine for early Alzheimer's Disease. It focuses on people in the early stages of Alzheimer's, aiming to improve their condition through multiple mechanisms.

Lenalidomide

Immunomodulator

Recruiting0 awardsPhase 2

This trial will investigate whether the immunomodulator lenalidomide can help treat Alzheimer's by reducing inflammation.

AVP-786

Behavioural Intervention

Recruiting1 awardPhase 3

This trial tests a combination of two drugs taken by mouth to help calm severe agitation in people with Alzheimer's disease by balancing brain chemicals.

ACU193

Monoclonal Antibodies

Recruiting0 awardsPhase 2

This trial aims to test if ACU193 infusions given every four weeks can help slow down mental and physical decline in people with early Alzheimer's disease compared to a placebo.

Donanemab

Monoclonal Antibodies

Recruiting1 awardPhase 3

This trial is testing donanemab, a drug for early Alzheimer's disease. It targets people with early symptoms and specific brain changes. The drug helps remove harmful proteins from the brain, potentially slowing down or improving symptoms.

Popular Filters

Phase 3 Trials

Anti-amyloid agent

ALZ-801 for Early Alzheimer's Disease

Recruiting2 awardsPhase 3

Las Vegas, Nevada

"This trial is looking at how safe and effective ALZ-801 is for people with Early Alzheimer's disease who have a specific genetic marker. Participants will receive treatment with ALZ-801 in an open

AR1001 for Alzheimer's Disease

Recruiting1 awardPhase 3

Las Vegas, Nevada

This trial tests AR1001, a medicine for early Alzheimer's Disease. It focuses on people in the early stages of Alzheimer's, aiming to improve their condition through multiple mechanisms.

Remternetug for Alzheimer's Disease

Recruiting1 awardPhase 3

Las Vegas, Nevada

This trial tests remternetug, a drug given by injection or IV, in people with early Alzheimer's disease. It aims to find out if the drug is safe and can help improve symptoms or slow down the disease.

Behavioural Intervention

AVP-786 for Alzheimer's-related Agitation

Recruiting1 awardPhase 3

Las Vegas, Nevada

This trial tests a combination of two drugs taken by mouth to help calm severe agitation in people with Alzheimer's disease by balancing brain chemicals.

Monoclonal Antibodies

Donanemab for Early Alzheimer's Disease

Recruiting1 awardPhase 3

Redlands, California

This trial is testing donanemab, a drug for early Alzheimer's disease. It targets people with early symptoms and specific brain changes. The drug helps remove harmful proteins from the brain, potentially slowing down or improving symptoms.

Monoclonal Antibodies

Donanemab for Alzheimer's Disease

Recruiting1 awardPhase 3

Las Vegas, Nevada

This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.